Key Points One of the more bullish analysts tracking the company reiterated her enthusiastic buy recommendation on the biotech. She has flagged it as one of her firm's best stock ideas for this year. 10 stocks we like better than Edgewise Therapeutics › As investors, we should never underestimate the power of a convincing buy recommendation from an analyst. That was the dynamic behind the impressi...
Key Points One of the more bullish analysts tracking the company reiterated her enthusiastic buy recommendation on the biotech. She has flagged it as one of her firm's best stock ideas for this year. 10 stocks we like better than Edgewise Therapeutics › As investors, we should never underestimate the power of a convincing buy recommendation from an analyst. That was the dynamic behind the impressive rise of Edgewise Therapeutics (NASDAQ: EWTX) stock on Monday; after a pundit who's been tracking the biotech for some time reiterated her bullish view on its potential, investors traded it up by 4% on the day. That crushed the 0.5% increase of the bellwether S&P 500 index. A bull stays the course The analyst in question was Piper Sandler's Yasmeen Rahimi. Monday morning, she reiterated her overweight recommendation on Edgewise's equity and her $51 per share price target. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » In fact, according to reports, Rahimi considers Edgewise to be one of Piper Sandler's best stock ideas for this year. This conviction centers around the company's leading cardiovascular drug candidate, EDG-7500, a treatment that targets a genetic heart condition called hypertrophic cardiomyopathy (HCM). The treatment is currently in a Phase 2 clinical trial, with a readout expected in the second quarter of this calendar year. In the analyst's view, its novel functionality sets it apart from HCM treatments currently on the market, which should give it an edge when and if it is approved for commercialization. A muscular development effort That's not the only ace up Edgewise's sleeve, in Rahimi's view. She wrote that several of the company's other pipeline programs have solid potential, and I'd readily agree. In addition to those cardiovascular drugs, the company is also well advanced in developing Sevasemten, a muscular dystrophy treatment...
(RTTNews) - Freedom Holding Corp. (FRHC) released earnings for third quarter that Dropped, from the same period last year The company's bottom line totaled $76.24 million, or $1.25 per share. This compares with $78.28 million, or $1.29 per share, last year. The company's revenue for the period fell 5.4% to $628.62 million from $664.58 million last year. Freedom Holding Corp. earnings at a glance (...
(RTTNews) - Freedom Holding Corp. (FRHC) released earnings for third quarter that Dropped, from the same period last year The company's bottom line totaled $76.24 million, or $1.25 per share. This compares with $78.28 million, or $1.29 per share, last year. The company's revenue for the period fell 5.4% to $628.62 million from $664.58 million last year. Freedom Holding Corp. earnings at a glance (GAAP) : -Earnings: $76.24 Mln. vs. $78.28 Mln. last year. -EPS: $1.25 vs. $1.29 last year. -Revenue: $628.62 Mln vs. $664.58 Mln last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Shares of the tech giant fell after it posted its latest earnings numbers in January. It's been a tough start to 2026 for Microsoft (MSFT +3.24%), which is down more than 10% thus far and in danger of falling below $3 trillion in market cap. It would be a symbolic exclamation mark of the decline this normally stable stock has been on of late. It's currently down around 25% from its 52-week high of...
Shares of the tech giant fell after it posted its latest earnings numbers in January. It's been a tough start to 2026 for Microsoft (MSFT +3.24%), which is down more than 10% thus far and in danger of falling below $3 trillion in market cap. It would be a symbolic exclamation mark of the decline this normally stable stock has been on of late. It's currently down around 25% from its 52-week high of $555.45. What's gotten investors so down on the stock of late? And is this a great opportunity to invest in one of the largest tech companies in the world, or could Microsoft's stock be heading for more of a decline in the weeks and months ahead? Microsoft's latest earnings numbers didn't impress investors Last month, Microsoft released its second-quarter earnings, which covered the last three months of 2025. It was a solid quarter for the business as revenue of $81.3 billion was up 17% year over year. But what seemed to alarm investors was a worse-than-expected growth rate in its cloud business, Azure. At 39%, it was slightly below what analysts expected and down from 40% growth in the previous period. Azure is a key growth catalyst for Microsoft, and any hint of a slowdown there can often raise concerns for growth investors, which appears to be what has happened here. This is even as CEO Satya Nadella speaks fondly of the company's growing artificial intelligence (AI) business, saying that the company is "only at the beginning phases of AI diffusion and already Microsoft has built an AI business that is larger than some of our biggest franchises." Expand NASDAQ : MSFT Microsoft Today's Change ( 3.24 %) $ 12.98 Current Price $ 414.12 Key Data Points Market Cap $3.0T Day's Range $ 400.88 - $ 414.89 52wk Range $ 344.79 - $ 555.45 Volume 2.1M Avg Vol 30M Gross Margin 68.59 % Dividend Yield 0.85 % Why now might be a great time to buy Microsoft's stock Amid the post-earnings sell-off, Microsoft's stock fell to levels it hadn't been at since April of last year, when concerns ar...
Key Points Many of the issues that plagued Wolfspeed before it went bankrupt remain. The company is seeing a negative gross margin and negative cash flow. Meanwhile, its revenue is also declining. 10 stocks we like better than Wolfspeed › Coming out of bankruptcy, Wolfspeed (NYSE: WOLF) was expected to offer investors a way to play the silicon carbide market without the shackles of its overly burd...
Key Points Many of the issues that plagued Wolfspeed before it went bankrupt remain. The company is seeing a negative gross margin and negative cash flow. Meanwhile, its revenue is also declining. 10 stocks we like better than Wolfspeed › Coming out of bankruptcy, Wolfspeed (NYSE: WOLF) was expected to offer investors a way to play the silicon carbide market without the shackles of its overly burdensome debt. However, the company's fiscal second-quarter earnings report showed that many of the problems that plagued the company and led to its bankruptcy still exist. Issues remain Two of Wolfspeed's biggest issues before bankruptcy were negative gross margins and operating cash flow. And those two issues continued to be a problem when the company reported its fiscal Q2 2026 results. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » For the quarter, which ended Dec. 28, 2025, Wolfspeed recorded a negative gross margin of 46%, hurt by costs from inventory reserves and fresh start accounting, as well as the continued underutilization of its manufacturing facility. It expects its gross margin to remain negative in fiscal Q3 2026 as it continues to deal with operational issues. Following the bankruptcy, the company's debt was greatly reduced from $13.6 billion to $1.7 billion in debt, of which $1.4 billion is in the form of a convertible note. It also had $1.3 billion in cash on its balance sheet. The company did continue to bleed cash in the quarter, with negative operating cash flow of $42.6 million. However, the bulk of its spending is behind it, so its negative free cash flow was just $72.6 million. Revenue, meanwhile, fell 7% to $168.5 million. Silicon carbide was supposed to be a game changer in the electric vehicle (EV) market, as it performs better than silicon at high temperatures, helping performa...
Key Points In recent months, investors have been turning to silver and gold as safe-haven assets, rather than Bitcoin. The cryptocurrency hasn't fared particularly well when investors are feeling bearish about the economy. 10 stocks we like better than Bitcoin › Bitcoin (CRYPTO: BTC) hasn't proven to be much of a safe-haven asset this year. It's down around 20% since the start of 2026, as investor...
Key Points In recent months, investors have been turning to silver and gold as safe-haven assets, rather than Bitcoin. The cryptocurrency hasn't fared particularly well when investors are feeling bearish about the economy. 10 stocks we like better than Bitcoin › Bitcoin (CRYPTO: BTC) hasn't proven to be much of a safe-haven asset this year. It's down around 20% since the start of 2026, as investors have been turning to gold and silver as ways to hedge their risk. The cryptocurrency has recently hit a new 52-week low of just over $60,000. Back in April of last year, when the market was concerned about reciprocal tariffs weighing on the economy, Bitcoin reached lows of around $75,000, and ended up roaring back. Is the world's top cryptocurrency a no-brainer buy while it remains below that threshold? Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » Will Bitcoin bounce back in 2026? Bitcoin began to fall in value in the latter part of 2025, as investors grew concerned about valuations and a possible stock market bubble. And rather than turning to Bitcoin, they appeared to load up on gold and silver, as those metals have reached record highs this year. The cryptocurrency has typically done well when investors are bullish about the economy rather than bearish, with a prime example being what happened on the markets in 2022, when the S&P 500 fell by 19% as a result of rising inflation -- the price of Bitcoin plummeted 65% that year. With economic conditions looking shaky and plenty of uncertainty still ahead, I wouldn't hold my breath that a potentially rally is coming up for Bitcoin anytime soon. Is Bitcoin worth buying now? Bitcoin is a highly speculative asset to put in your portfolio. Its price movements over the past several months highlight that risk. The danger is that it can be extremely difficult to predict which direction it might go in, and un...
Key Points Microsoft's stock hasn't been this cheap in months. The company's Azure business grew at a slighter slower rate than expected in Q2. However, Microsoft still expects plenty of growth ahead, especially in artificial intelligence. 10 stocks we like better than Microsoft › It's been a tough start to 2026 for Microsoft (NASDAQ: MSFT), which is down more than 10% thus far and in danger of fa...
Key Points Microsoft's stock hasn't been this cheap in months. The company's Azure business grew at a slighter slower rate than expected in Q2. However, Microsoft still expects plenty of growth ahead, especially in artificial intelligence. 10 stocks we like better than Microsoft › It's been a tough start to 2026 for Microsoft (NASDAQ: MSFT), which is down more than 10% thus far and in danger of falling below $3 trillion in market cap. It would be a symbolic exclamation mark of the decline this normally stable stock has been on of late. It's currently down around 25% from its 52-week high of $555.45. What's gotten investors so down on the stock of late? And is this a great opportunity to invest in one of the largest tech companies in the world, or could Microsoft's stock be heading for more of a decline in the weeks and months ahead? Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » Microsoft's latest earnings numbers didn't impress investors Last month, Microsoft released its second-quarter earnings, which covered the last three months of 2025. It was a solid quarter for the business as revenue of $81.3 billion was up 17% year over year. But what seemed to alarm investors was a worse-than-expected growth rate in its cloud business, Azure. At 39%, it was slightly below what analysts expected and down from 40% growth in the previous period. Azure is a key growth catalyst for Microsoft, and any hint of a slowdown there can often raise concerns for growth investors, which appears to be what has happened here. This is even as CEO Satya Nadella speaks fondly of the company's growing artificial intelligence (AI) business, saying that the company is "only at the beginning phases of AI diffusion and already Microsoft has built an AI business that is larger than some of our biggest franchises." Why now might be a great time to buy Microsoft's stock Amid the ...